Pseudohypoaldosteronism Differential Diagnoses
- Author: Alicia Diaz-Thomas, MD, MPH; Chief Editor: Stephen Kemp, MD, PhD more...
Diagnostic Considerations
In addition to the conditions listed in the differential diagnosis, other problems to be considered include the following:
- Addison disease
- Chronic renal failure
- Isolated hypoaldosteronism
- Nephronophthisis
- Obstructive uropathy[12]
- Salt-wasting nephropathies
Differential Diagnoses
- 17-Hydroxylase Deficiency Syndrome
- 3-Beta-Hydroxysteroid Dehydrogenase Deficiency
- Acute Tubular Necrosis
- Adrenal Glands
- Adrenal Hypoplasia
- Adrenal Insufficiency
- Cerebral Salt-Wasting Syndrome
- Chronic Kidney Disease
- Cystic Fibrosis
- Dehydration
- Failure to Thrive
Melzi ML, Guez S, Sersale G, et al. Acute pyelonephritis as a cause of hyponatremia/hyperkalemia in young infants with urinary tract malformations. Pediatr Infect Dis J. Jan 1995;14(1):56-9. [Medline].
Geller DS, Zhang J, Zennaro MC, et al. Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults. J Am Soc Nephrol. 2006;17:1429-1436. [Medline].
Chitayat D, Spirer Z, Ayalon D, Golander A. Pseudohypoaldosteronism in a female infant and her family: diversity of clinical expression and mode of inheritance. Acta Paediatr Scand. Jul 1985;74(4):619-22. [Medline].
Hogg R, Marks J, Marver D, Frolich J. Long-term observation in a patient with pseudohypoaldosteronism. Pediatr Nephrol. 1991;5:205-210. [Medline].
Huang CL, Cha SK, Wang HR, Xie J, Cobb MH. WNKs: protein kinases with a unique kinase domain. Exp Mol Med. 2007;39:565-73. [Medline].
Tobias JD, Brock JW III, Lynch A. Pseudohypoaldosteronism following operative correction of unilateral obstructive nephropathy. Clin Pediatr (Phila). Jun 1995;34(6):327-30. [Medline].
Valimaki M, Pelkonen R, Tikkanem I, Fyhriquist F. Normal renin sensitivity to atrial natriuretic peptide in Gordon's syndrome. Pediatr Nephrol. 1992;6:44-45. [Medline].
Sheridan MB, Fong P, Groman JD, et al. Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. Hum Mol Genet. 2005;14:3493-3498. [Medline].
Adachi M, Asakura Y, Muroya K, Tajima T, Fujieda K, Kuribayashi E, et al. Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism. Clin Exp Nephrol. Apr 8 2010;[Medline].
Mansfield TA, Simon DB, Farfel Z, et al. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet. Jun 1997;16(2):202-5. [Medline].
Chang SS, Grunder S, Hanukoglu A, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet. Mar 1996;12(3):248-53. [Medline].
Mastrandrea LD, Martin DJ, Springate JE. Clinical and biochemical similarities between reflux/obstructive uropathy and salt-wasting congenital adrenal hyperplasia. Clin Pediatr (Phila). 2005;44:809-812. [Medline].
Perimenis P, Wemeau JL, Vantyghem MC. Hypercalciuria [French]. Ann Endocrinol (Paris). 2005;66:532-539. [Medline].
| Details | PHA Type I | PHA Type II | |||
| Renal PHA-I | MTOD PHA-I | Early Childhood Hyperkalemia | PHA-II | ||
| Synonyms | Classic PHA of infancy, Cheek and Perry syndrome, autosomal dominant PHA-I, subtype 4 RTA IV | Autosomal recessive PHA-I | Subtype 5 RTA IV | Adolescent hyperkalemic syndrome, Spitzer-Weinstein syndrome, subtype 3 RTA IV | Gordon syndrome, mineralocorticoid-resistant hyperkalemia, chloride shunt syndrome |
| Age | Newborn period, infancy | Newborn period, infancy | Infancy, childhood | Childhood | Adulthood |
| Organs | Kidney | Kidney, sweat glands, salivary glands, colon | Kidney | Kidney | Kidney |
| Genetics | Autosomal dominant, sporadic | Autosomal recessive, sporadic | Unknown | Unknown | Autosomal dominant, sporadic |
| Mechanism | Heterozygous MLR mutations (possible) | Defective Na transport in organs that contain ENaC | Maturation disorder in the number or function of aldosterone receptors | Chloride shunt | Chloride shunt |
| Serum potassium | High | High | High | High | High |
| Acidosis | Present | Present | Present | Present | Present |
| Serum sodium | Normal or low | Normal or low | Normal | Normal | Normal |
| PRA* | High | High | Normal or high | Normal or low | Low |
| Aldosterone | High | High | Normal or high | Normal or low | Low |
| Blood volume | Normovolemia, hypovolemia | Normovolemia, hypovolemia | Normovolemia | Hypervolemia | Hypervolemia |
| Blood pressure | Normal or low | Normal or low | Normal or low | Normal or low | Normal or low |
| GFR | Normal | Normal | Normal | Normal | Normal |
| Salt wasting | Renal | Renal, sweat or salivary glands, colon | Absent | Absent | Absent |
| Hypercalciuria | Present or absent | Absent | Absent | Present | Present |
| Therapy | Na supplementation, K-binding resins | High-Na, low-K diet, K-binding resins, hydrochlorothiazide | Na bicarbonate, K-binding resins | Dietary Na restriction, hydrochlorothiazide | Dietary Na restriction, hydrochlorothiazide |
| Prognosis | Outgrow by age 2 y | Lifelong therapy | Outgrow by age 5 y | Lifelong therapy | Lifelong therapy |
| *Plasma renin activity. ENaC = epithelial sodium channel; GFR = glomerular filtration rate; MLR = mineralocorticoid receptor gene; PHA = pseudohypoaldosteronism; RTA = renal tubular acidosis. | |||||

